as 07-09-2025 9:54am EST
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Founded: | 1989 | Country: | United States |
Employees: | N/A | City: | IRVINE |
Market Cap: | 8.2B | IPO Year: | 2007 |
Target Price: | $187.00 | AVG Volume (30 days): | 579.3K |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -9.23 | EPS Growth: | N/A |
52 Week Low/High: | $101.61 - $194.88 | Next Earning Date: | 08-05-2025 |
Revenue: | $2,126,800,000 | Revenue Growth: | 16.68% |
Revenue Growth (this year): | -25.99% | Revenue Growth (next year): | 7.74% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Muhsin Bilal | MASI | Chief Operating Officer | May 12 '25 | Sell | $163.73 | 10,000 | $1,632,781.24 | 30,291 |
MASI Breaking Stock News: Dive into MASI Ticker-Specific Updates for Smart Investing
StockStory
12 days ago
StockStory
a month ago
Argus Research
a month ago
Business Wire
a month ago
StockStory
a month ago
StockStory
a month ago
StockStory
a month ago
Cybersecurity Dive
a month ago
The information presented on this page, "MASI Masimo Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.